November 15, 2018
Add to Twitter
English | عربي
 
Israel's Intec Pharma Looks to Start Profiting Massively Off of Parkinson's Drug -Palestine
Jeffrey Meckler, Intec's chief executive, said that the pill to treat Parkinson's could be worth more than $300 million a year
 
News Agencies Feed